These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 19428887)

  • 1. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge.
    Shang L; Liu Q; Liu W; Men J; Gao S; Jiang L; Wang Z; Zhai Y; Jin H; Lian H; Chen C; Xia Z; Yuan Z; Zhu XQ
    Vaccine; 2009 May; 27(21):2741-5. PubMed ID: 19428887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ
    Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
    Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18.
    Liu Q; Shang L; Jin H; Wei F; Zhu XQ; Gao H
    Res Vet Sci; 2010 Aug; 89(1):93-7. PubMed ID: 20132954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice.
    Zhang G; Huang X; Boldbaatar D; Battur B; Battsetseg B; Zhang H; Yu L; Li Y; Luo Y; Cao S; Goo YK; Yamagishi J; Zhou J; Zhang S; Suzuki H; Igarashi I; Mikami T; Nishikawa Y; Xuan X
    Vaccine; 2010 Oct; 28(45):7243-7. PubMed ID: 20832493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis.
    Hoseinian Khosroshahi K; Ghaffarifar F; D'Souza S; Sharifi Z; Dalimi A
    Vaccine; 2011 Jan; 29(4):778-83. PubMed ID: 21095254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.
    Machado AV; Caetano BC; Barbosa RP; Salgado AP; Rabelo RH; Garcia CC; Bruna-Romero O; Escriou N; Gazzinelli RT
    Vaccine; 2010 Apr; 28(18):3247-56. PubMed ID: 20189485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice.
    Cui YL; He SY; Xue MF; Zhang J; Wang HX; Yao Y
    Parasite Immunol; 2008 May; 30(5):309-13. PubMed ID: 18331395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
    Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
    J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic Eimeria tenella as a vaccine vehicle: expressing TgSAG1 elicits protective immunity against Toxoplasma gondii infections in chickens and mice.
    Tang X; Yin G; Qin M; Tao G; Suo J; Liu X; Suo X
    Sci Rep; 2016 Jul; 6():29379. PubMed ID: 27387302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.